anmelden
OMX Nordic 40
2.683,58
PKT
-27,66
PKT
-1,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.12.18 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 11.12.18 | Volvo (B) Sell | UBS AG | |
| 11.12.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 11.12.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.12.18 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 11.12.18 | Nokia overweight | JP Morgan Chase & Co. | |
| 10.12.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 10.12.18 | ABB (Asea Brown Boveri) buy | HSBC | |
| 08.12.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 07.12.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 06.12.18 | Volvo (B) Underweight | Morgan Stanley | |
| 05.12.18 | ABB (Asea Brown Boveri) neutral | Morgan Stanley | |
| 03.12.18 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 03.12.18 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 30.11.18 | Novo Nordisk buy | UBS AG | |
| 29.11.18 | Nokia Outperform | Credit Suisse Group | |
| 29.11.18 | Novo Nordisk neutral | Kepler Cheuvreux | |
| 28.11.18 | AstraZeneca Reduce | HSBC | |
| 26.11.18 | Novo Nordisk Reduce | HSBC | |
| 26.11.18 | Novo Nordisk buy | UBS AG | |
| 23.11.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 23.11.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 19.11.18 | AstraZeneca Neutral | UBS AG | |
| 19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 19.11.18 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.11.18 | Nokia Outperform | Credit Suisse Group | |
| 19.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 16.11.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.11.18 | Nokia Outperform | Credit Suisse Group | |
| 13.11.18 | Fortum Sell | Goldman Sachs Group Inc. | |
| 13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.18 | AstraZeneca Reduce | HSBC | |
| 12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.11.18 | AstraZeneca Hold | CFRA | |
| 09.11.18 | AstraZeneca overweight | Barclays Capital |
